The association of depression with treatment and disability in multiple sclerosis;Multipl skleroz'da tedavi, özürlülük ve depresyon arasındaki i̇lişki

Noropsikiyatri Arsivi

Volumn 49, Issue 4, 2012, Pages 300-303

  Tanik, Nermin ^a   Aydin, Adem ^b   Selvi, Yavuz ^b   Güleç, Mustafa ^c   Anlar, Ömer ^d   Tombul, Temel ^b  

^a Van E itim ve Ara tirma Hastanesi   (Turkey)

^b YUZUNCU YIL UNIVERSITY   (Turkey)

^c ATATURK UNIVERSITY   (Turkey)

^d ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Depression; Disability; Multiple sclerosis; Treatment

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PATIENT ASSESSMENT; PHYSICAL DISABILITY; RISK FACTOR; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84871462778     PISSN: 13000667     EISSN: None     Source Type: Journal    
DOI: 10.4274/npa.y6253     Document Type: Article

References (29)

1. Schiffer RB. Disturbances of affect. In: Rao SM, editör. Neurobehavioral aspects of multiple sclerosis. Newyork: Oxford University Press; 1990.
2. Uǧuz F, Akpinar Z, Özkan I, Tokgöz S. Multipl Sklerozlu hastalarda major depresyon ve yaşam kalitesi ilişkisi. Noropsikiyatri Arşivi 2008; 45:28-31.
3. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatique and depression. J Neurol Sci 2002; 205:51-58.
4. Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klösch G, Kollegger H, Kristoferitsch W, Zeitlhofer J. Factors influencing quality of life in multiple sclerosis patients: Disability, depressive mood, fatique and sleep quality. Acta Neurol Scand 2004; 110:6-13.
5. Skegg K, Corwin PA, Skegg DC. How often is MS mistaken for a psychiatric disorder. Psychol Med 1988; 18:733-736.
6. Matthews B. Symptoms and signs of multiple sclerosis. McAlpine's Multiple Sclerosis, 3 ed. London: Churchill Livingstone 1998; 145-190.
7. Benedict RH, Fishman I, McClellan MM, Bakshi R, Weinstock-Guttman B. Validity of the Beck Depression Inventory-Fast screen in multiple sclerosis. Mult Scler 2003; 9:393-396.
8. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444-1452.
9. Aksel Siva ve Türk Multipl Skleroz Çali{dotless}şma Grubu. Edirne şehir merkezinde MS prevelans çali{dotless}şmasi{dotless}. 39. Ulusal Nöroloji Kongresi program ve bildiri özet kitabi{dotless} 2003 s: 248.
10. Barclay L, Lie D. International panel revises McDonald diagnostic criteria for multiple sclerosis. Ann Neurol 2005; 58:840-846.
11. Azzimondi G, Stracciari A, Rinaldi R,D'Alessandro R, Pazzaglia P. Multiple sclerosis with very late onset: report of six cases and review of the literature. Eur Neuro 1994; 134:332-336.
12. Azzimondi G, Stracciari A, Rinaldi R, D'Alessandro R, Pazzaglia P. Biological and psychological aspects of depression. Behav Ther 1991; 22:201-228.
13. Feinstein A, Roy P, Lobaugh N, Feinstein K, O'Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004; 62:586-590.
14. Öztürk O. Ruh saǧli{dotless}ǧi{dotless} ve bozukluklari{dotless}. 2004; 10:295.
15. Patten SB, Beck CA, Williams JV, Barbui C, Metz LM. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003; 61:1524-1527.
16. Pujol J, Bello J, Deus J, Martí-Vilalta JL, Capdevila A. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 1997; 49:1105-1110.
17. Feinstein A. Multiple sclerosis, disease modifying treatments and depression: a critical methodological review. Mult Scler 2000; 6:343-348.
18. Whitlock FA, Siskind MM. Depression as a major symptom of multiple sclerosis. J Neurol Neurosurg Psychiatry 1980; 43:861-865.
19. Mendes MF, Tilbery CP, Balsimelli S, Moreira MA, Barão-Cruz AM. Depression in relapsing-remitting multiple sclerosis. Arq Neuropsiquiatr 2003; 61:591-595.
20. Iwasaki Y, Iwamoto K, Igarashi O, Kiyozuka T, Aoyagi J, Hirano K, Sato R, Kawase Y, Iwasa Y, Ikeda K. Depression in multipl sclerosis. Acta Neurol Scand 2005; 111:209.
21. Walsh A, Walsh PA. Love, self-esteem and multiple sclerosis. Soc Sci Med 1989; 29:793-798.
22. Sánchez López MP, Olivares Pérez T, Nieto Barco A, Hernández Pérez MA, Barroso Ribal J. Multipl sclerosis and depression. Rev Neurol 2004; 38:524-529.
23. Craner MJ, Zajicek JP. Immunosuppressive treatments in MS side effects from azathioprine. J Neurol 2001; 248:625-626.
24. Silberberg DH. Azathioprine in MS: The cons. Neurology 1988; 38:24-27.
25. Fratiglioni L, Siracusa GF, Amato MP, Sità D, Amaducci L. Effectiveness of azathioprine treatment in MS. Ital J Neurol Sci 1988; 9:261-264.
26. Patten SB, Metz LM. Interferon b-1a and depression in relapsing-remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial. Mult Scler 2001; 7:243-248.
27. Feinstein A, O'Connor P, Feinstein K. Multiple sclerosis, interferon beta-1b and depression: a prospective investigation. J Neurol 2002; 249:815-820.
28. Mohr DC, Likosky W, Dwyer P, Van Der Wende J, Boudewyn AC, Goodkin DE. Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis. Arch Neurol 1999; 56:1263-1265.
29. Patten SB, Francis G, Metz LM, Lopez-Bresnahan M, Chang P, Curtin F. The Relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis. Mult Scler 2005; 11:175-181.